$SVA.V Sernova Corp 🚀🚀🚀
Sernova Corp ($SVA:TSXV $SEOVF:OTC) is a company working on a "Functional Cure" for many diseases including diabetes, post-operative hypothyroid, and hemophilia A. They make a small implantable device that is inserted under the skin which vascularizes with the bloodstream. They then place theraputic cells into the pouch, giving them access to the bloodstream and these cells begin to function as if they were in their respective organs, naturally.
They are currently about a year+ into a Chicago Based Phase I/II FDA clinical trial for a type 1 diabetes treatment and on Janurary 15th, the principal investigator, Dr. Piotr Witkowski announced that their furthest along patient had been INSULIN INDEPENDENT for 9 months thus far. This means that somebody who’s body was producing literally 0 insulin was now naturally producing enough insulin to completely sustain normal bloodsurgar levels. The pateint no longer required daily insulin injections. This is huge. The share price went from $0.70 cents to $2.80 in 2 days. After which some investors took profits while the rest have been holding strong and the share price has slowly sank to an amazingly discounted price of around $1.40 a share.
So the diabetes market is roughly a $40 Billion dollar market yearly and this device would completely disrupt that entire market! Adding in the hypothryoid and hemophilia markets you can tack on roughly another $10 Billion in potential revenue.
Now why should you care, currently the stock is trading at like an average of 600k shares daily with over 250 million shares outstanding. That means most investors are holding strong as they await the next update on the FDA trial. So when is this update coming? Well on June 27th 2021, Dr. Witkowski will be presenting at the 2021 Spring Symposium at the American Diabetes Association and should be providing us with an update. We should hear about how some of the other patients are doing in the trial. The results could send this stock to the moon!
Additionally, Sernova has said that they are in multiple collaborations with multiple major pharmaceutical companies. If they were able to secure a licensing deal with any other these companies then the stock could sore as well.
Basically, the cell therapy sector is really heating up and Sernova is the only company World Wide to show positive trial results and they are offering a delivery vehicle for potentially any cell therapy solution.
This company presents a ton of potential and presents an opportunity to get involved at the early stages while it is still cheap.
Note: This is not financial advice and I am not a financial advisor.
via r/wallstreetbets https://ift.tt/3qhG8Zq
May 8, 2021 at 05:12PM